Home
Research Trends
Scientific Articles
Journals
Scientific Journals
Open Access Journals
Journals Search
Contact
Sign Up
Login
Language
English
German
Journal of Alzheimer's Disease
Title
Publication Date
Language
Citations
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?
2005/03/03
63
Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
2017/04/19
49
Alzheimer's Disease and the Amyloid-β Peptide
2010/01/06
31
Role of Glutamate and NMDA Receptors in Alzheimer’s Disease
2017/04/19
27
Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways
2008/05/09
24
Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis
2019/08/13
20
Mini-Mental State Examination in Elderly Chinese: A Population-Based Normative Study
2016/07/13
20
Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults
2008/04/14
20
Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease
2018/03/13
19
Neurobiology of COVID-19
2020/06/30
19
Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates
2014/08/11
19
Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease
2007/03/01
18
The Gut Microbiota and Alzheimer’s Disease
2017/05/03
18
Religious Orders Study and Rush Memory and Aging Project
2018/06/12
17
Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine
2005/12/05
17
Determining the Presence of Periodontopathic Virulence Factors in Short-Term Postmortem Alzheimer's Disease Brain Tissue
2013/08/05
16
Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein
2001/03/05
15
Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease
2018/03/13
14
GSK3 and Tau: Two Convergence Points in Alzheimer's Disease
2012/12/27
14
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons
2017/04/19
14
Linguistic Features Identify Alzheimer’s Disease in Narrative Speech
2015/11/27
13
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
2018/05/30
13
Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease
2006/07/14
13
Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis
2014/06/23
12
From Aging to Alzheimer's Disease: Unveiling “The Switch” with the Senescence-Accelerated Mouse Model (SAMP8)
2008/12/17
12
Earliest Stages of Tau Conformational Changes are Related to the Appearance of a Sequence of Specific Phospho-Dependent Tau Epitopes in Alzheimer's Disease1
2007/12/25
12
Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer's disease
2005/03/03
12
The Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review
2018/04/24
12
Alzheimer’s Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State
2017/01/12
12
Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
2019/02/12
12
«
‹ Pervious
Next ›
»